spot_img
Sunday, July 3, 2022
More
    HomeHealthSierra Oncology drug improves anemia and other myelofibrosis symptoms

    Sierra Oncology drug improves anemia and other myelofibrosis symptoms

    -



    Sierra Oncology stated Tuesday that its experimental therapy for the blood most cancers myelofibrosis achieved all of the efficacy targets of a Part 3 medical trial, together with an enchancment in anemia that at the moment permitted medicine don’t handle.

    Primarily based on the optimistic examine outcomes, Sierra intends to file a U.S. advertising utility for its drug, referred to as momelotinib, through the second quarter. If permitted, the drug will enter a myelofibrosis therapy market that’s dominated by Jakafi, the Incyte/Novartis drug with gross sales exceeding $2 billion yearly.

    Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!

    GET STARTED





    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,380FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts